Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

<p>FOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) — Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that Guo-Liang Yu, Ph.D., Co-Founder and Chief Executive Officer of Apollomics and Sanjeev Redkar, Ph.D., Co-Founder and President, will participate in a Fireside […]</p>
<p>The post <a href="https://forextv.com/top-news/apollomics-to-participate-in-a-fireside-chat-at-the-h-c-wainwright-4th-annual-precision-oncology-virtual-conference/">Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>